Otsuka Holdings Co., Ltd. (TYO:4578)
Japan
· Delayed Price · Currency is JPY 7,075.00
-161.00 (-2.22%)
May 9, 2025, 3:30 PM JST
Otsuka Holdings Revenue
Otsuka Holdings had revenue of 582.84B JPY in the quarter ending March 31, 2025, with 12.19% growth. This brings the company's revenue in the last twelve months to 2.39T, up 14.52% year-over-year. In the year 2024, Otsuka Holdings had annual revenue of 2.33T with 15.42% growth.
Revenue (ttm)
2,393.18B
Revenue Growth
+14.52%
P/S Ratio
1.57
Revenue / Employee
67.72M
Employees
35,338
Market Cap
3,746.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,329.86B | 311.29B | 15.42% |
| Dec 31, 2023 | 2,018.57B | 280.57B | 16.14% |
| Dec 31, 2022 | 1,738.00B | 239.72B | 16.00% |
| Dec 31, 2021 | 1,498.28B | 75.45B | 5.30% |
| Dec 31, 2020 | 1,422.83B | 26.59B | 1.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |
| Shionogi & | 456.87B |
Otsuka Holdings News
- 2 months ago - Full Year 2024 Otsuka Holdings Co Ltd Earnings Presentation Transcript - GuruFocus
- 3 months ago - Otsuka Holdings reports FY results - Seeking Alpha
- 6 months ago - Otsuka Holdings Co., Ltd. reports Q3 results - Seeking Alpha
- 7 months ago - Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific - BNN Bloomberg